Missouri Legal Cannabis Market (2026 - 2033)

Missouri Legal Cannabis Market Summary

The Missouri legal cannabis market size was valued at USD 2.2 billion in 2025 and is projected to grow from USD 2.6 billion in 2026 to USD 9.6 billion in 2033, at a CAGR of 20.4% from 2026 to 2033. The growing disease burden of chronic pain and increasing requirement for pain management therapies across Missouri are the key factors driving this growth. In addition, rising legalization and awareness of the health benefits of cannabis consumption are expected to drive demand. Growing research on the benefits of marijuana on human health, increasing patient awareness, and the prevalence of chronic diseases are also contributing to market expansion.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

The legalization of adult-use cannabis in Missouri has substantially expanded the state's regulated cannabis industry by increasing consumer access, encouraging investments across the value chain, and supporting the establishment of licensed cultivation, manufacturing, and retail facilities. The presence of an expanding network of state-authorized dispensaries, coupled with growing research into cannabis applications, continues to drive market development.

The market is also witnessing growing participation from established cannabis companies seeking to strengthen their retail footprint and broaden product accessibility. For instance, in October 2025, Curio Wellness announced a definitive agreement to acquire 4 Greenlight dispensaries in Missouri, expanding its retail presence across Southeast Missouri and strengthening consumer access to its cannabis product portfolio.

The regulatory environment is also evolving to support a safe and transparent cannabis marketplace. In April 2026, the Missouri Department of Health and Senior Services expanded its "Verified Dispensary: We're on the List" initiative by introducing additional consumer awareness programs and digital verification tools to help consumers identify licensed dispensaries. The initiative is expected to strengthen consumer confidence, improve regulatory compliance, and reinforce the integrity of Missouri's market.

Analyst Perspective

The market is supported by increasing consumer acceptance of adult-use cannabis, expanding licensed retail infrastructure, and sustained demand for medical cannabis products. Ongoing investments in dispensary acquisitions, cultivation capacity expansion, and product innovation are strengthening market competitiveness and improving product accessibility across the state. Continued regulatory oversight, increasing availability of premium cannabis derivatives, and portfolio diversification by leading operators are expected to reinforce long-term market development.

Source Insights

The marijuana segment held the largest market share of around 45.0% in 2025, and is expected to maintain its dominance over the forecast period. The main factors driving growth in the segment include the established medical and recreational cannabis system in Missouri, rising consumer demand for regulated cannabis products, and the licensing of new dispensaries in the region. Products derived from marijuana, such as flower, oil, and concentrates, remain popular owing to their higher THC content and broad therapeutic as well as recreational applications. For instance, in December 2026, Mfused entered the Missouri market through a partnership with Curio Wellness, expanding the availability of premium cannabis vape products and strengthening the state's marijuana product portfolio.

The hemp segment is anticipated to register the fastest CAGR during the forecast period, driven by rising demand for hemp-based health and wellness products, as well as for CBD supplements and industrial hemp products. The increasing consumer inclination towards non-psychoactive cannabis products, along with innovative product development, is set to propel segment growth. The use of hemp-based components in functional foods and cosmetics is also contributing to market uptake in Missouri.

Derivatives Insights

The THC segment held the largest revenue share of over 35.0% in 2025, owing to strong consumer demand for adult-use cannabis products and increasing purchases of THC-rich flower, concentrates, and infused products through licensed dispensaries. The expansion of recreational cannabis sales and continuous product innovation by cultivators and manufacturers have further strengthened segment growth. For instance, in February 2026, Standard Wellness partnered with DABSTRACT to manufacture and distribute premium cannabis concentrates in Missouri, expanding the availability of high-quality THC-based products.

The CBD segment is expected to witness the fastest CAGR during the forecast period due to increasing consumer awareness of the potential wellness benefits of cannabidiol, which lacks psychoactive effects. Growing adoption of CBD products for pain management, anxiety relief, sleep support, and general wellness, coupled with expanding product availability across pharmacies, wellness stores, and online platforms, is expected to accelerate market growth throughout the forecast period.

Cultivation Insights

The indoor cultivation segment accounted for more than 42.0% of revenue in 2025. Indoor cultivation enables growers to maintain strict environmental controls, ensuring consistent product quality, higher cannabinoid potency, and compliance with Missouri's regulatory standards. The majority of licensed commercial cultivation facilities in the state continue to rely on indoor production to meet the growing demand for premium cannabis products supplied to medical and adult use dispensaries.

The greenhouse cultivation segment is projected to register the fastest CAGR during the forecast period, driven by the growing investment in cost-effective cultivation technology. Cultivation in greenhouses strikes a balance between efficiency and production quality, with lower energy requirements than indoor production. With cultivators looking to minimize production costs and expand their facilities, greenhouse cultivation is set to be increasingly embraced in Missouri.

End Use Insights

The recreational segment accounted for over 65.0% of market revenue in 2025 and is expected to register the fastest growth over the forecast period. Growth is supported by expanding adult-use cannabis sales, increasing consumer participation, and the continued expansion of licensed dispensary networks across Missouri. In addition, recreational cannabis legalization has generated additional tax revenues while contributing to the transition from the illicit market to regulated cannabis sales.

The medical segment accounted for the second-largest revenue share in 2025. Continued physician acceptance, expanding clinical research on therapeutic cannabis applications, and increasing patient awareness are supporting demand for medical cannabis products. The evolving regulatory framework has improved patient access through licensed dispensaries, while growing acceptance of cannabis for the management of chronic pain, neurological disorders, and other qualifying conditions continues to strengthen the medical cannabis segment.

Key Missouri Legal Cannabis Company Insights

The Missouri market is characterized by established multi-state operators and regional cannabis companies competing through dispensary expansion, cultivation capacity expansion, product portfolio diversification, and strategic acquisitions. Market participants continue to invest in premium cannabis products, branded retail networks, and vertically integrated operations to strengthen their competitive position and expand consumer reach across the state.

Key Missouri Legal Cannabis Companies

The following key companies have been profiled for this study on the Missouri legal cannabis market:

• BeLeaf Medical

• Blue Sage Cannabis Co.

• Show Me Alternatives

• Heya Wellness

• Missouri Wild Alchemy

• Organic Remedies

• Holistic Industries

• Kansas City Cannabis

• LOCAL CANNABIS COMPANY

• MOcann Extracts

Recent Developments

• In June 2025, Vireo Growth Inc. completed the acquisition of Proper Brands, one of Missouri's largest independent cannabis operators. Through the transaction, Vireo acquired Proper Brands' network of 11 dispensaries along with a cultivation and manufacturing facility exceeding 100,000 square feet, significantly strengthening its retail, cultivation, and production capabilities in Missouri's adult-use cannabis market.

Missouri Legal Cannabis Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global Missouri legal cannabis market report based on source, derivatives, cultivation, and end-use:

• Source Outlook (Revenue, USD Billion, 2021 - 2033)

  • Hemp

    • Hemp CBD

    • Industrial Hemp

  • Marijuana

    • Flower

    • Oil and Tinctures

• Derivatives Outlook (Revenue, USD Billion, 2021 - 2033)

  • CBD

  • THC

  • Others

• Cultivation Outlook (Revenue, USD Billion, 2021 - 2033)

  • Indoor Cultivation

  • Greenhouse Cultivation

  • Outdoor Cultivation

• End Use Outlook (Revenue, USD Billion, 2021 - 2033)

  • Industrial Use

  • Medical Use

    • Chronic Pain

    • Depression and Anxiety

    • Arthritis

    • Post-traumatic Stress Disorder (PTSD)

    • Cancer

    • Migraines

    • Epilepsy

    • Alzheimer’s

    • Multiple Sclerosis

    • AIDS

    • Amyotrophic Lateral Sclerosis

    • Tourette’s

    • Diabetes

    • Parkinson's

    • Glaucoma

    • Others

  • Recreational Use